|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 28
Zeitschriftenartikel
Brioli, Annamaria 
ORCID: https://orcid.org/0000-0002-4072-7592; Lomaia, Elza ORCID: https://orcid.org/0000-0003-3290-7961; Fabisch, Christian; Sacha, Tomasz ORCID: https://orcid.org/0000-0002-7207-6595; Klamova, Hana; Morozova, Elena; Golos, Aleksandra; Ernst, Philipp ORCID: https://orcid.org/0000-0001-5165-9874; Olsson-Stromberg, Ulla; Zackova, Daniela; Nicolini, Franck E.; Bao, Han; Castagnetti, Fausto ORCID: https://orcid.org/0000-0002-0602-2628; Patkowska, Elzbieta ORCID: https://orcid.org/0000-0001-8691-4310; Mayer, Jiri; Hirschbühl, Klaus ORCID: https://orcid.org/0000-0002-4847-7460; Podgornik, Helena ORCID: https://orcid.org/0000-0003-3752-2067; Paczkowska, Edyta ORCID: https://orcid.org/0000-0001-7052-9741; Parry, Anne; Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X; Voskanyan, Astghik; Szczepanek, Elzbieta; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Franke, Georg-Nikolaus ORCID: https://orcid.org/0000-0001-8239-002X; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Faber, Edgar; Krause, Stefan ORCID: https://orcid.org/0000-0002-5259-4651; Casado, Luis Felipe; Lewandowski, Krzysztof; Eder, Matthias; Anhut, Peter; Gil, Justyna; Südhoff, Thomas; Hebart, Holger ORCID: https://orcid.org/0000-0003-4536-9955; Heibl, Sonja; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas und Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127
(2024):
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry.
In: Leukemia [Forthcoming]
ORCID: https://orcid.org/0000-0002-4072-7592; Lomaia, Elza ORCID: https://orcid.org/0000-0003-3290-7961; Fabisch, Christian; Sacha, Tomasz ORCID: https://orcid.org/0000-0002-7207-6595; Klamova, Hana; Morozova, Elena; Golos, Aleksandra; Ernst, Philipp ORCID: https://orcid.org/0000-0001-5165-9874; Olsson-Stromberg, Ulla; Zackova, Daniela; Nicolini, Franck E.; Bao, Han; Castagnetti, Fausto ORCID: https://orcid.org/0000-0002-0602-2628; Patkowska, Elzbieta ORCID: https://orcid.org/0000-0001-8691-4310; Mayer, Jiri; Hirschbühl, Klaus ORCID: https://orcid.org/0000-0002-4847-7460; Podgornik, Helena ORCID: https://orcid.org/0000-0003-3752-2067; Paczkowska, Edyta ORCID: https://orcid.org/0000-0001-7052-9741; Parry, Anne; Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X; Voskanyan, Astghik; Szczepanek, Elzbieta; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Franke, Georg-Nikolaus ORCID: https://orcid.org/0000-0001-8239-002X; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Faber, Edgar; Krause, Stefan ORCID: https://orcid.org/0000-0002-5259-4651; Casado, Luis Felipe; Lewandowski, Krzysztof; Eder, Matthias; Anhut, Peter; Gil, Justyna; Südhoff, Thomas; Hebart, Holger ORCID: https://orcid.org/0000-0003-4536-9955; Heibl, Sonja; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas und Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127
(2024):
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry.
In: Leukemia [Forthcoming]
Mahon, Francois-Xavier ORCID: https://orcid.org/0000-0003-1545-6775; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Dulucq, Stéphanie ORCID: https://orcid.org/0000-0003-2728-7243; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834; Panayiotidis, Panayiotis; Almeida, Antonio ORCID: https://orcid.org/0000-0003-4361-0928; Mayer, Jiri ORCID: https://orcid.org/0000-0003-0567-9887; Hjorth-Hansen, Henrik ORCID: https://orcid.org/0000-0002-2670-5696; Janssen, Jeroen J.W.M.; Mustjoki, Satu ORCID: https://orcid.org/0000-0002-0816-8241; Martinez-Lopez, Joaquin ORCID: https://orcid.org/0000-0001-7908-0063; Vestergaard, Hanne; Ehrencrona, Hans ORCID: https://orcid.org/0000-0002-5589-3622; Machová Poláková, Katerina; Olsson-Strömberg, Ulla; Ossenkoppele, Gert; Berger, Marc G. ORCID: https://orcid.org/0000-0003-1858-0587; Etienne, Gabriel ORCID: https://orcid.org/0000-0001-7600-4954; Dengler, Jolanta; Brümmendorf, Tim H. ORCID: https://orcid.org/0000-0002-9677-3723; Burchert, Andreas ORCID: https://orcid.org/0000-0002-8411-8844; Réa, Delphine ORCID: https://orcid.org/0000-0001-5379-7461; Rousselot, Philippe; Nicolini, Franck E.; Hofmann, Wolf-Karsten; Richter, Johan; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Mayer, Jiri; Voglová, Jaroslava; Faber, Edgar; Klamova, Hana; Vestergaard, Hanne; Koskenvesa, Perttu; Mahon, Francois-Xavier; Etienne, Gabriel; Berger, Marc G.; Rousselot, Philippe; Nicolini, Franck E.; Charbonnier, Aude; Legros, Laurence; Réa, Delphine; Guilhot, François; Escoffre-Barbe, Martine; Huguet, Françoise; Gyan, Emmanuel; Brümmendorf, Tim Henrik; Waller, Cornelius; Dengler, Jolanta; Hochhaus, Andreas; Saußele, Susanne; Burchert, Andreas; Kunzmann, Volker; Pagoni, Maria N.; Panayiotidis, Panayiotis; Janssen, Jeroen J.W.M.; Ossenkoppele, Gert; Westerweel, Peter E.; Greef, Georgine E. de; Gruber, Franz; Hjorth-Hansen, Henrik; Almeida, Antonio; Martinez-Lopez, Joaquin; Lotfi, Kourosh; Richter, Johan; Stenke, Leif; Olsson-Strömberg, Ulla und Söderlund, Stina
(2024):
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission.
In: Journal of Clinical Oncology [Forthcoming]
ORCID: https://orcid.org/0000-0003-1545-6775; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Dulucq, Stéphanie ORCID: https://orcid.org/0000-0003-2728-7243; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834; Panayiotidis, Panayiotis; Almeida, Antonio ORCID: https://orcid.org/0000-0003-4361-0928; Mayer, Jiri ORCID: https://orcid.org/0000-0003-0567-9887; Hjorth-Hansen, Henrik ORCID: https://orcid.org/0000-0002-2670-5696; Janssen, Jeroen J.W.M.; Mustjoki, Satu ORCID: https://orcid.org/0000-0002-0816-8241; Martinez-Lopez, Joaquin ORCID: https://orcid.org/0000-0001-7908-0063; Vestergaard, Hanne; Ehrencrona, Hans ORCID: https://orcid.org/0000-0002-5589-3622; Machová Poláková, Katerina; Olsson-Strömberg, Ulla; Ossenkoppele, Gert; Berger, Marc G. ORCID: https://orcid.org/0000-0003-1858-0587; Etienne, Gabriel ORCID: https://orcid.org/0000-0001-7600-4954; Dengler, Jolanta; Brümmendorf, Tim H. ORCID: https://orcid.org/0000-0002-9677-3723; Burchert, Andreas ORCID: https://orcid.org/0000-0002-8411-8844; Réa, Delphine ORCID: https://orcid.org/0000-0001-5379-7461; Rousselot, Philippe; Nicolini, Franck E.; Hofmann, Wolf-Karsten; Richter, Johan; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Mayer, Jiri; Voglová, Jaroslava; Faber, Edgar; Klamova, Hana; Vestergaard, Hanne; Koskenvesa, Perttu; Mahon, Francois-Xavier; Etienne, Gabriel; Berger, Marc G.; Rousselot, Philippe; Nicolini, Franck E.; Charbonnier, Aude; Legros, Laurence; Réa, Delphine; Guilhot, François; Escoffre-Barbe, Martine; Huguet, Françoise; Gyan, Emmanuel; Brümmendorf, Tim Henrik; Waller, Cornelius; Dengler, Jolanta; Hochhaus, Andreas; Saußele, Susanne; Burchert, Andreas; Kunzmann, Volker; Pagoni, Maria N.; Panayiotidis, Panayiotis; Janssen, Jeroen J.W.M.; Ossenkoppele, Gert; Westerweel, Peter E.; Greef, Georgine E. de; Gruber, Franz; Hjorth-Hansen, Henrik; Almeida, Antonio; Martinez-Lopez, Joaquin; Lotfi, Kourosh; Richter, Johan; Stenke, Leif; Olsson-Strömberg, Ulla und Söderlund, Stina
(2024):
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission.
In: Journal of Clinical Oncology [Forthcoming]
Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Hehlmann, Rüdiger; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Saußele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2023):
Survival with chronic myeloid leukaemia after failing milestones.
In: Leukemia, Bd. 37: S. 2231-2236
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-6662-7127; Hehlmann, Rüdiger; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Saußele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2023):
Survival with chronic myeloid leukaemia after failing milestones.
In: Leukemia, Bd. 37: S. 2231-2236
[PDF, 1MB]
Isfort, Susanne ORCID: https://orcid.org/0000-0002-2855-561X; Manz, Kirsi ORCID: https://orcid.org/0000-0002-7740-4076; Teichmann, Lino L.; Crysandt, Martina; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Kiani, Alexander; Göthert, Joachim R.; Illmer, Thomas; Schafhausen, Philippe; Al-Ali, Haifa Kathrin; Stegelmann, Frank; Hänel, Mathias; Pfeiffer, Tim; Giagounidis, Aristoteles; Franke, Georg-Nikolaus; Koschmieder, Steffen; Fabarius, Alice; Ernst, Thomas; Warnken-Uhlich, Mareille; Wolber, Uta; Kohn, Denise; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Wolf, Dominik und Brümmendorf, Tim H.
(2023):
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
In: Annals of Hematology, Bd. 102: S. 2741-2752
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-2855-561X; Manz, Kirsi ORCID: https://orcid.org/0000-0002-7740-4076; Teichmann, Lino L.; Crysandt, Martina; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Kiani, Alexander; Göthert, Joachim R.; Illmer, Thomas; Schafhausen, Philippe; Al-Ali, Haifa Kathrin; Stegelmann, Frank; Hänel, Mathias; Pfeiffer, Tim; Giagounidis, Aristoteles; Franke, Georg-Nikolaus; Koschmieder, Steffen; Fabarius, Alice; Ernst, Thomas; Warnken-Uhlich, Mareille; Wolber, Uta; Kohn, Denise; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Wolf, Dominik und Brümmendorf, Tim H.
(2023):
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
In: Annals of Hematology, Bd. 102: S. 2741-2752
[PDF, 1MB]
Niederwieser, Dietger ORCID: https://orcid.org/0000-0002-4737-1103; Lang, Thomas; Krahl, Rainer; Heinicke, Thomas; Maschmeyer, Georg; Al-Ali, Haifa Kathrin; Schwind, Sebastian; Jentzsch, Madlen; Cross, Michael; Kahl, Christoph; Wolf, Hans-Heinrich; Sayer, Herbert; Schulze, Antje; Dreger, Peter; Hegenbart, Ute; Krämer, Alwin; Junghanss, Christian; Mügge, Lars-Olof; Hähling, Detlev; Hirt, Carsten; Späth, Christian; Peter, Norma; Opitz, Bernhard; Florschütz, Axel; Reifenrath, Kolja; Zojer, Niklas; Scholl, Sebastian; Pönisch, Wolfram; Heyn, Simone; Vucinic, Vladan; Hochhaus, Andreas; Aul, Carlo; Giagounidis, Aristoteles; Balleisen, Leopold; Oldenkott, Bernd; Staib, Peter; Kiehl, Michael; Schütte, Wolfgang; Naumann, Ralph; Eimermacher, Hartmut; Dörken, Bernd; Sauerland, Cristina; Lengfelder, Eva; Hiddemann, Wolfgang; Wörmann, Bernhard; Müller-Tidow, Carsten; Serve, Hubert; Schliemann, Christoph; Hehlmann, Rüdiger; Berdel, Wolfgang E.; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Krug, Utz und Hoffmann, Verena S. ORCID: https://orcid.org/0000-0003-1478-5390
(2023):
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
In: Annals of Hematology, Bd. 102: S. 547-561
[PDF, 3MB]
ORCID: https://orcid.org/0000-0002-4737-1103; Lang, Thomas; Krahl, Rainer; Heinicke, Thomas; Maschmeyer, Georg; Al-Ali, Haifa Kathrin; Schwind, Sebastian; Jentzsch, Madlen; Cross, Michael; Kahl, Christoph; Wolf, Hans-Heinrich; Sayer, Herbert; Schulze, Antje; Dreger, Peter; Hegenbart, Ute; Krämer, Alwin; Junghanss, Christian; Mügge, Lars-Olof; Hähling, Detlev; Hirt, Carsten; Späth, Christian; Peter, Norma; Opitz, Bernhard; Florschütz, Axel; Reifenrath, Kolja; Zojer, Niklas; Scholl, Sebastian; Pönisch, Wolfram; Heyn, Simone; Vucinic, Vladan; Hochhaus, Andreas; Aul, Carlo; Giagounidis, Aristoteles; Balleisen, Leopold; Oldenkott, Bernd; Staib, Peter; Kiehl, Michael; Schütte, Wolfgang; Naumann, Ralph; Eimermacher, Hartmut; Dörken, Bernd; Sauerland, Cristina; Lengfelder, Eva; Hiddemann, Wolfgang; Wörmann, Bernhard; Müller-Tidow, Carsten; Serve, Hubert; Schliemann, Christoph; Hehlmann, Rüdiger; Berdel, Wolfgang E.; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Krug, Utz und Hoffmann, Verena S. ORCID: https://orcid.org/0000-0003-1478-5390
(2023):
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
In: Annals of Hematology, Bd. 102: S. 547-561
[PDF, 3MB]
Kunadt, Desiree; Stasik, Sebastian; Metzeler, Klaus H.; Roellig, Christoph; Schliemann, Christoph; Greif, Philipp A.; Spiekermann, Karsten; Rothenberg-Thurley, Maja; Krug, Utz; Braess, Jan; Kraemer, Alwin; Hochhaus, Andreas; Scholl, Sebastian; Hilgendorf, Inken; Bruemmendorf, Tim H.; Jost, Edgar; Steffen, Bjoern; Bug, Gesine; Einsele, Hermann; Goerlich, Dennis; Sauerland, Cristina; Schaefer-Eckart, Kerstin; Krause, Stefan W.; Haenel, Mathias; Hanoun, Maher; Kaufmann, Martin; Woermann, Bernhard; Kramer, Michael; Sockel, Katja; Egger-Heidrich, Katharina; Herold, Tobias; Ehninger, Gerhard; Burchert, Andreas; Platzbecker, Uwe; Berdel, Wolfgang E.; Mueller-Tidow, Carsten; Hiddemann, Wolfgang; Serve, Hubert; Stelljes, Matthias; Baldus, Claudia D.; Neubauer, Andreas; Schetelig, Johannes; Thiede, Christian; Bornhaeuser, Martin; Middeke, Jan M. und Stoelzel, Friedrich
(2022):
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation.
In: Journal of Hematology & Oncology, Bd. 15, Nr. 1, 126
Middeke, Jan M.; Metzeler, Klaus H.; Roellig, Christoph; Kraemer, Michael; Eckardt, Jan-Niklas; Stasik, Sebastian; Greif, Philipp A.; Spiekermann, Karsten; Rothenberg-Thurley, Maja; Krug, Utz; Braess, Jan; Kraemer, Alwin; Hochhaus, Andreas; Bruemmendorf, Tim H.; Naumann, Ralph; Steffen, Bjoern; Einsele, Hermann; Schaich, Markus; Burchert, Andreas; Neubauer, Andreas; Goerlich, Dennis; Sauerland, Cristina; Schaefer-Eckart, Kerstin; Schliemann, Christoph; Krause, Stefan W.; Haenel, Mathias; Frickhofen, Norbert; Noppeney, Richard; Kaiser, Ulrich; Kaufmann, Martin; Kunadt, Desiree; Woermann, Bernhard; Sockel, Katja; Bonin, Malte von; Herold, Tobias; Mueller-Tidow, Carsten; Platzbecker, Uwe; Berdel, Wolfgang E.; Serve, Hubert; Baldus, Claudia D.; Ehninger, Gerhard; Schetelig, Johannes; Hiddemann, Wolfgang; Bornhaeuser, Martin; Stoelzel, Friedrich und Thiede, Christian
(2022):
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study.
In: Blood Advances, Bd. 6, Nr. 5: S. 1394-1405
Hehlmann, Rüdiger; Lauseker, Michael ORCID: https://orcid.org/0000-0002-6662-7127; Voskanyan, Astghik; Fabarius, Alice; Haferlach, Claudia ORCID: https://orcid.org/0000-0002-6333-5049; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Saußele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2022):
Impact of emerging ACA on survival in chronic myeloid leukemia (CML).
In: Leukemia, Bd. 36: S. 2544-2547
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-6662-7127; Voskanyan, Astghik; Fabarius, Alice; Haferlach, Claudia ORCID: https://orcid.org/0000-0002-6333-5049; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Saußele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785
(2022):
Impact of emerging ACA on survival in chronic myeloid leukemia (CML).
In: Leukemia, Bd. 36: S. 2544-2547
[PDF, 1MB]
Schönfeld, Lioba; Rinke, Jenny; Hinze, Anna; Nagel, Saskia N.; Schäfer, Vivien; Schenk, Thomas; Fabisch, Christian; Brümmendorf, Tim H. ORCID: https://orcid.org/0000-0002-9677-3723; Burchert, Andreas ORCID: https://orcid.org/0000-0002-8411-8844; Coutre, Philipp le; Krause, Stefan W. ORCID: https://orcid.org/0000-0002-5259-4651; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Safizadeh, Fatemeh; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X
(2022):
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia.
In: Leukemia, Bd. 36: S. 2242-2249
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-9677-3723; Burchert, Andreas ORCID: https://orcid.org/0000-0002-8411-8844; Coutre, Philipp le; Krause, Stefan W. ORCID: https://orcid.org/0000-0002-5259-4651; Saussele, Susanne ORCID: https://orcid.org/0000-0003-0357-5785; Safizadeh, Fatemeh; Pfirrmann, Markus ORCID: https://orcid.org/0000-0002-8948-0690; Hochhaus, Andreas ORCID: https://orcid.org/0000-0003-0626-0834 und Ernst, Thomas ORCID: https://orcid.org/0000-0003-2147-489X
(2022):
ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia.
In: Leukemia, Bd. 36: S. 2242-2249
[PDF, 1MB]
Brioli, Annamaria ORCID: https://orcid.org/0000-0002-4072-7592; Manz, Kirsi ORCID: https://orcid.org/0000-0002-7740-4076; Pfirrmann, Markus; Hänel, Mathias; Schwarzer, Andreas Christoph; Prange-Krex, Gabriele; Fabisch, Christian; Knop, Stefan; Illmer, Thomas; Krammer-Steiner, Beate; Hochhaus, Andreas; Lilienfeld-Toal, Marie von und Mügge, Lars-Olof
(2. März 2020):
Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN).
In: Journal of cancer research and clinical oncology, Bd. 146, Nr. 3: S. 749-759
ORCID: https://orcid.org/0000-0002-4072-7592; Manz, Kirsi ORCID: https://orcid.org/0000-0002-7740-4076; Pfirrmann, Markus; Hänel, Mathias; Schwarzer, Andreas Christoph; Prange-Krex, Gabriele; Fabisch, Christian; Knop, Stefan; Illmer, Thomas; Krammer-Steiner, Beate; Hochhaus, Andreas; Lilienfeld-Toal, Marie von und Mügge, Lars-Olof
(2. März 2020):
Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN).
In: Journal of cancer research and clinical oncology, Bd. 146, Nr. 3: S. 749-759
Pfirrmann, Markus; Clark, Richard E.; Prejzner, Witold; Lauseker, Michael; Baccarani, Michele; Saussele, Susanne; Guilhot, François; Hasford, Joerg; Hochhaus, Andreas und Hoffmann, Verena S.
(2020):
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia.
In: Leukemia, Bd. 34, Nr. 8: S. 2138-2149
[PDF, 969kB]
Schwaab, Juliana; Naumann, Nicole; Luebke, Johannes; Jawhar, Mohamad; Somervaille, Tim C. P.; Williams, Mark S.; Frewin, Rebecca; Jost, Philipp J.; Lichtenegger, Felix S.; La Rosee, Paul; Storch, Nicola; Haferlach, Torsten; Horny, Hans-Peter; Fabarius, Alice; Haferlach, Claudia; Burchert, Andreas; Hofmann, Wolf-Karsten; Cross, Nicholas C. P.; Hochhaus, Andreas; Reiter, Andreas und Metzgeroth, Georgia
(2020):
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.
In: American Journal of Hematology, Bd. 95, Nr. 7: S. 824-833
Herrmann, Andreas B.; Müller, Martha-Lena; Orth, Martin F.; Müller, Jörg P.; Zernecke, Alma; Hochhaus, Andreas; Ernst, Thomas; Butt, Elke und Frietsch, Jochen J.
(2020):
Knockout of LASP1 in CXCR4 expressing CML cells promotes cell persistence, proliferation and TKI resistance.
In: Journal of Cellular and Molecular Medicine, Bd. 24, Nr. 5: S. 2942-2955
Butt, Elke; Stempfle, Katrin; Lister, Lorenz; Wolf, Felix; Kraft, Marcella; Herrmann, Andreas B.; Viciano, Cristina Perpina; Weber, Christian; Hochhaus, Andreas; Ernst, Thomas; Hoffmann, Carsten; Zernecke, Alma und Frietsch, Jochen J.
(2020):
Phosphorylation-Dependent Differences in CXCR4-LASP1-AKT1 Interaction between Breast Cancer and Chronic Myeloid Leukemia.
In: Cells, Bd. 9, Nr. 2, 444
Lauseker, Michael; Bachl, Katharina; Turkina, Anna; Faber, Edgar; Prejzner, Witold; Olsson-Strömberg, Ulla; Baccarani, Michele; Lomaia, Elza; Zackova, Daniela; Ossenkoppele, Gert; Griskevicius, Laimonas; Schubert-Fritschle, Gabriele; Sacha, Tomasz; Heibl, Sonja; Koskenvesa, Perttu; Bogdanovic, Andrija; Clark, Richard E.; Guilhot, Joelle; Hoffmann, Verena S.; Hasford, Joerg; Hochhaus, Andreas und Pfirrmann, Markus
(November 2019):
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin.
In: American Journal of Hematology, Bd. 94, Nr. 11: S. 1236-1243
[PDF, 1MB]
Michel, Christian; Burchert, Andreas; Hochhaus, Andreas; Saussele, Susanne; Neubauer, Andreas; Lauseker, Michael; Krause, Stefan W.; Kolb, Hans-Jochem; Hossfeld, Dieter Kurt; Nerl, Christoph; Baerlocher, Gabriela M.; Heim, Dominik; Brümmendorf, Alice and Haferlach und Pfirrmann, Markus
(2019):
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
In: Haematologica, Bd. 104, Nr. 5: S. 955-962
Saussele, Susanne; Richter, Johan; Guilhot, Joelle; Gruber, Franz X.; Hjorth-Hansen, Henrik; Almeida, Antonio; Janssen, Jeroen J. W. M.; Mayer, Jiri; Koskenvesa, Perttu; Panayiotidis, Panayiotis; Olsson-Strömberg, Ulla; Martinez-Lopez, Joaquin; Rousselot, Philippe; Vestergaard, Hanne; Ehrencrona, Hans; Kairisto, Veli; Machová Poláková, Katerina; Müller, Martin C.; Mustjoki, Satu; Berger, Marc G.; Fabarius, Alice; Hofmann, Wolf-Karsten; Hochhaus, Andreas; Pfirrmann, Markus und Mahon, Francois-Xavier
(2018):
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): A prespecified interim analysis of a prospective, multicentre, non-randomised, trial.
In: The Lancet, Bd. 19, Nr. 6: S. 747-757
Saussele, Susanne; Hehlmann, Rüdiger; Fabarius, Alice; Jeromin, Sabine; Proetel, Ulrike; Rinaldetti, Sebastien; Kohlbrenner, Katharina; Einsele, Hermann; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F.; Oppliger Leibundgut, Elisabeth; Heim, Dominik; Krause, Stefan W.; Hofmann, Wolf-Karsten; Hasford, Joerg; Pfirrmann, Markus; Müller, Martin C.; Hochhaus, Andreas und Lauseker, Michael
(2018):
Defining therapy goals for major molecular remission in chronic myeloid leukemia: Results of the randomized CML Study IV.
In: Leukemia, Bd. 32, Nr. 5: S. 1222-1228
[PDF, 599kB]
Schütz, C.; Inselmann, S.; Saussele, Susanne; Dietz, C. T.; Müller, M. C.; Eigendorff, E.; Brendel, C. A.; Metzelder, S. K.; Brümmendorf, T. H.; Waller, C.; Dengler, J.; Goebeler, M. E.; Herbst, R.; Freunek, G.; Hanzel, S.; Illmer, Thomas; Wang, Y.; Lange, T.; Finkernagel, F.; Hehlmann, Rüdiger; Huber, M.; Neubauer, A.; Hochhaus, Andreas; Guilhot, Joelle; Mahon, F. X.; Pfirrmann, Markus und Burchert, A.
(2018):
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.
In: Leukemia, Bd. 32, Nr. 4
Drube, Julia; Ernst, Thomas; Pfirrmann, Markus; Albert, Benadict Vincent; Drube, Sebastian; Reich, Daniela; Kresinsky, Anne; Halfter, Kathrin; Sorio, Claudio; Fabisch, Christian; Hochhaus, Andreas und Böhmer, Frank-D
(2018):
PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cells.
In: Oncotarget, Bd. 9, Nr. 10: S. 9442-9455
Pulewka, Kristin; Wolff, Daniel; Herzberg, Philipp Y.; Greinix, Hildegard; Heussner, Pia; Mumm, Friederike H. A.; Harsdorf, Stephanie von; Rieger, Kathrin; Hemmati, Philipp; Hochhaus, Andreas und Hilgendorf, Inken
(2017):
Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial.
In: Journal of Cancer Research and Clinical Oncology, Bd. 143, Nr. 8: S. 1613-1619
Hehlmann, Rüdiger; Lauseker, Michael; Saußele, Susanne; Hochhaus, Andreas; Hasford, Joerg; Pfirrmann, Markus; Kolb, Hans-Jochem; Spiekermann, Karsten; Fabarius, Alice; Müller, M. C.; Proetel, Ulrike; Kohlbrenner, K.; Voskanyan, A.; Rinaldetti, S.; Seifarth, W.; Spieß, B.; Krause, S. W.; Neubauer, A.; Burchert, A.; Hossfeld, Dieter K.; Schafhausen, P.; Nerl, C.; Gratwohl, A.; Heim, D.; Baerlocher, Gabriela M.; Brümmendorf, Tim H.; Fuchs, R.; Haferlach, C.; Jeromin, S.; Schlegelberger, Brigitte; Balleisen, L.; Goebeler, M. C.; Hänel, M.; Ho, A.; Dengler, J.; Falge, C.; Kanz, L.; Kremers, S.; Kneba, M.; Stegelmann, F.; Köhne, C. A.; Lindemann, H. W.; Waller, C. F.; Pfreundschuh, Michael; Berdel, Wolfgang E.; Müller, L.; Edinger, M.; Mayer, J.; Beelen, D. W.; Bentz, M.; Link, H.; Hertenstein, Bernd; Wernli, Martin; Schlegel, F.; Schlag, R.; Wit, M. de; Trumper, L.; Hebart, H.; Hahn, M.; Thomalla, J.; Scheid, C.; Verbeek, W.; Eckart, M. J.; Gassmann, W.; Pezzutto, A.; Schenk, M.; Brossart, P.; Geer, T.; Bildat, S. und Schäfer, E.
(2017):
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.
In: Leukemia, Bd. 31, Nr. 11: S. 2398-2406
Engert, Andreas; Balduini, Carlo; Brand, Anneke; Coiffier, Bertrand; Cordonnier, Catherine; Döhner, Hartmut; Duyvené de Wit, Thom; Eichinger, Sabine; Fibbe, Willem; Green, Tony; Haas, Fleur de; Iolascon, Achille; Jaffredo, Thierry; Rodeghiero, Francesco; Salles, Gilles; Schuringa, Jan Jacob; Andre, Marc; Andre-Schmutz, Isabelle; Bacigalupo, Andrea; Bochud, Pierre-Yves; den Boer, Monique; Bonini, Chiara; Camaschella, Clara; Cant, Andrew; Cappellini, Maria Domenica; Cazzola, Mario; Lo Celso, Cristina; Dimopoulos, Meletios; Douay, Luc; Dzierzak, Elaine; Einsele, Hermann; Ferreri, Andres; De Franceschi, Lucia; Gaulard, Philippe; Gottgens, Berthold; Greinacher, Andreas; Gresele, Paolo; Gribben, John; Haan, Gerald de; Hansen, John-Bjarne; Hochhaus, Andreas; Kadir, Rezan; Kaveri, Srini; Kouskoff, Valerie; Kuehne, Thomas; Kyrle, Paul; Ljungman, Per; Maschmeyer, Georg; Mendez-Ferrer, Simon; Milsom, Michael; Mummery, Christine; Ossenkoppele, Gert; Pecci, Alessandro; Peyvandi, Flora; Philipsen, Sjaak; Reitsma, Pieter; Maria Ribera, Jose; Risitano, Antonio; Rivella, Stefano; Ruf, Wolfram; Schroeder, Timm; Scully, Marie; Socie, Gerard; Staal, Frank; Stanworth, Simon; Stauder, Reinhard; Stilgenbauer, Stephan; Tamary, Hannah; Theilgaard-Monch, Kim; Thein, Swee Lay; Tilly, Herve; Trneny, Marek; Vainchenker, William; Vannucchi, Alessandro Maria; Viscoli, Claudio; Vrielink, Hans; Zaaijer, Hans; Zanella, Alberto; Zolla, Lello; Zwaginga, Jaap Jan; Martinez, Patricia Aguilar; Akker, Emile van den; Allard, Shubha; Anagnou, Nicholas; Andolfo, Immacolata; Andrau, Jean-Christophe; Angelucci, Emanuele; Anstee, David; Aurer, Igor; Avet-Loiseau, Herve; Aydinok, Yesim; Bakchoul, Tamam; Balduini, Alessandra; Barcellini, Wilma; Baruch, Dominique; Baruchel, Andre; Bayry, Jagadeesh; Bento, Celeste; Berg, Anke van den; Bernardi, Rosa; Bianchi, Paola; Bigas, Anna; Biondi, Andrea; Bohonek, Milos; Bonnet, Dominique; Borchmann, Peter; Borregaard, Niels; Braekkan, Sigrid; Brink, Marcel van den; Brodin, Ellen; Bullinger, Lars; Buske, Christian; Butzeck, Barbara; Cammenga, Jorg; Campo, Elias; Carbone, Antonino; Cervantes, Francisco; Cesaro, Simone; Charbord, Pierre; Claas, Frans; Cohen, Hannah; Conard, Jacqueline; Coppo, Paul; Vives Corrons, Joan-Lluis; da Costa, Lydie; Davi, Frederic; Delwel, Ruud; Dianzani, Irma; Domanovic, Dragoslav; Donnelly, Peter; Drnovsek, Tadeja Dovc; Dreyling, Martin; Du, Ming-Qing; Dufour, Carlo; Durand, Charles; Efremov, Dimitar; Eleftheriou, Androulla; Elion, Jacques; Emonts, Marieke; Engelhardt, Monika; Ezine, Sophie; Falkenburg, Fred; Favier, Remi; Federico, Massimo; Fenaux, Pierre; Fitzgibbon, Jude; Flygare, Johan; Foa, Robin; Forrester, Lesley; Galacteros, Frederic; Garagiola, Isabella; Gardiner, Chris; Garraud, Olivier; Geet, Christel van; Geiger, Hartmut; Geissler, Jan; Germing, Ulrich; Ghevaert, Cedric; Girelli, Domenico; Godeau, Bertrand; Goekbuget, Nicola; Goldschmidt, Hartmut; Goodeve, Anne; Graf, Thomas; Graziadei, Giovanna; Griesshammer, Martin; Gruel, Yves; Guilhot, Francois; Gunten, Stephan von; Gyssens, Inge; Halter, Jorg; Harrison, Claire; Harteveld, Cornelis; Hellstrom-Lindberg, Eva; Hermine, Olivier; Higgs, Douglas; Hillmen, Peter; Hirsch, Hans; Hoskin, Peter; Huls, Gerwin; Inati, Adlette; Johnson, Peter; Kattamis, Antonis; Kiefel, Volker; Kleanthous, Marina; Klump, Hannes; Krause, Daniela; Hovinga, Johanna Kremer; Lacaud, Georges; Lacroix-Desmazes, Sebastien; Landman-Parker, Judith; LeGouill, Steven; Lenz, Georg; Lilienfeld-Toal, Marie von; Lindern, Marieke von; Lopez-Guillermo, Armando; Lopriore, Enrico; Lozano, Miguel; MacIntyre, Elizabeth; Makris, Michael; Mannhalter, Christine; Martens, Joost; Mathas, Stephan; Matzdorff, Axel; Medvinsky, Alexander; Menendez, Pablo; Migliaccio, Anna Rita; Miharada, Kenichi; Mikulska, Malgorzata; Minard, Veronique; Montalban, Carlos; de Montalembert, Mariane; Montserrat, Emili; Morange, Pierre-Emmanuel; Mountford, Joanne; Muckenthaler, Martina; Mueller-Tidow, Carsten; Mumford, Andrew; Nadel, Bertrand; Navarro, Jose-Tomas; el Nemer, Wassim; Noizat-Pirenne, France; O'Mahony, Brian; Oldenburg, Johannes; Olsson, Martin; Oostendorp, Robert; Palumbo, Antonio; Passamonti, Francesco; Patient, Roger; Peffault de Latour, Regis; Pflumio, Francoise; Pierelli, Luca; Piga, Antonio; Pollard, Debra; Raaijmakers, Marc; Radford, John; Rambach, Ralf; Rao, A. Koneti; Raslova, Hana; Rebulla, Paolo; Rees, David; Ribrag, Vincent; Rijneveld, Anita; Rinalducci, Sara; Robak, Tadeusz; Roberts, Irene; Rodrigues, Charlene; Rosendaal, Frits; Rosenwald, Andreas; Rule, Simon; Russo, Roberta; Saglio, Guiseppe; Sanchez, Mayka; Scharf, Ruediger E.; Schlenke, Peter; Semple, John; Sierra, Jorge; So-Osman, Cynthia; Manuel Soria, Jose; Stamatopoulos, Kostas; Stegmayr, Bernd; Stunnenberg, Henk; Swinkels, Dorine; Taborda Barata, Joao Pedro; Taghon, Tom; Taher, Ali; Terpos, Evangelos; Thachil, Jecko; Tissot, Jean Daniel; Touw, Ivo; Toye, Ash; Trappe, Ralf; Traverse-Glehen, Alexandra; Unal, Sule; Vaulont, Sophie; Viprakasit, Vip; Vitolo, Umberto; Wijk, Richard van; Wojtowicz, Agnieszka; Zeerleder, Sacha und Zieger, Barbara
(2016):
The European Hematology Association Roadmap for European Hematology Research: a consensus document.
In: Haematologica, Bd. 101, Nr. 2: S. 115-208
Lauseker, Michael; Hanfstein, Benjamin; Haferlach, Claudia; Schnittger, Susanne; Pfirrmann, Markus; Fabarius, Alice; Schlegelberger, Brigitte; Saußele, Susanne; Dietz, Christian T.; Erben, Philipp; Hehlmann, Rüdiger; Hasford, Joerg; Hochhaus, Andreas und Müller, Martin C.
(November 2014):
Equivalence of BCR-ABL transcript levels with complete cytogenetic remission in patients with chronic myeloid leukemia in chronic phase.
In: Journal of cancer research and clinical oncology, Bd. 140, Nr. 11: S. 1965-1969
Hehlmann, Rüdiger; Hasford, Joerg; Pfirrmann, Markus; Lauseker, Michael; Saußele, Susanne und Hochhaus, Andreas
(September 2014):
Reply to H. Kantarjian et al.
In: Journal of Clinical Oncology, Bd. 32, Nr. 27, 3078-3078
Proetel, Ulrike; Pletsch, Nadine; Lauseker, Michael; Müller, Martin C.; Hanfstein, Benjamin; Krause, Stefan W.; Kalmanti, Lida; Schreiber, Annette; Heim, Dominik; Baerlocher, Gabriela M.; Hofmann, Wolf-Karsten; Lange, Elisabeth; Einsele, Hermann; Wernli, Martin; Kremers, Stephan; Schlag, Rudolf; Müller, Lothar; Hänel, Mathias; Link, Hartmut; Hertenstein, Bernd; Pfirrmann, Markus; Hochhaus, Andreas; Hasford, Joerg; Hehlmann, Rüdiger und Saußele, Susanne
(Juli 2014):
Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.
In: Annals of Hematology, Bd. 93, Nr. 7: S. 1167-1176
[PDF, 985kB]
Hanfstein, Benjamin; Lauseker, Michael; Hehlmann, Rüdiger; Saussele, Susanne; Erben, Philipp; Dietz, Christian; Fabarius, Alice; Proetel, Ulrike; Schnittger, Susanne; Haferlach, Claudia; Krause, Stefan W.; Schubert, Joerg; Einsele, Hermann; Hänel, Mathias; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F.; Spiekermann, Karsten; Baerlocher, Gabriela M.; Pfirrmann, Markus; Hasford, Jörg; Hofmann, Wolf-Karsten; Hochhaus, Andreas und Müller, Martin C.
(2014):
Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib.
In: Haematologica, Bd. 99, Nr. 9: S. 1441-1447
[PDF, 784kB]
Hehlmann, Rüdiger; Hochhaus, Andreas; Kolb, Hans-Jochem; Hasford, Joerg; Gratwohl, Alois; Heimpel, Hermann; Siegert, Wolfgang; Finke, Jürgen; Ehninger, Gerhard; Holler, Ernst; Berger, Ute; Pfirrmann, Markus; Muth, Alexander; Zander, Alex; Fauser, Axel A.; Heyll, Axel; Nerl, Christoph; Hossfeld, Dieter K.; Löffler, Helmut; Pralle, Hans; Queißer, Wolfgang und Tobler, Andreas
(1. Dezember 1999):
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure.
In: Blood, Bd. 94, Nr. 11, 10572078: S. 3668-3677